Directori de persones
Gerard Josep Mauri Capdevila

Gerard Josep Mauri Capdevila


gmauri(ELIMINAR)@gencat.cat

Publicacions

  • Colàs-Campàs L; Farre, J; Mauri-Capdevila, G; Molina-Seguin, J; Aymerich, N; Ois, A; Roquer, J; Tur, S; García-Carreira MDC; Marti-Fabregas, J; Cruz-Culebras, A; Segura, T; Arque, G; Purroy, F

    Inflammatory Response of Ischemic Tolerance in Circulating Plasma: Preconditioning-Induced by Transient Ischemic Attack (TIA) Phenomena in Acute Ischemia Patients (AIS).

    Frontiers in Neurology 11 552470-552470. .

    [doi:10.3389/fneur.2020.552470]

  • Purroy, F; Arque, G; Mauri, G; Garcia-Vazquez, C; Vicente-Pascual, M; Pereira, C; Vazquez-Justes, D; Torres-Querol, C; Vena, A; Abilleira, S; Cardona, P; Forne, C; Jimenez-Fabrega, X; Pagola, J; Portero-Otin, M; Rodriguez-Campello, A; Rovira À; Marti-Fabregas, J

    REMOTE Ischemic Perconditioning Among Acute Ischemic Stroke Patients in Catalonia: REMOTE-CAT PROJECT.

    Frontiers in Neurology 11 569696-569696. .

    [doi:10.3389/fneur.2020.569696]

  • Purroy, F; Garcia, C; Mauri, G; Pereira, C; Torres, C; Vazquez-Justes, D; Vicente-Pascual, M; Vena, A; Arque, G

    Induced neuroprotection by remote ischemic perconditioning as a new paradigm in ischemic stroke at the acute phase, a systematic review.

    BMC NEUROLOGY 20 266-266. .

    [doi:10.1186/s12883-020-01836-8]

  • Purroy, F; Cambray, S; Mauri-Capdevila, G; Jove, M; Sanahuja, J; Farre, J; Benabdelhak, I; Molina-Seguin, J; Colàs-Campàs L; Begue, R; Gil, MI; Pamplona, R; Portero-Otin, M

    Metabolomics Predicts Neuroimaging Characteristics of Transient Ischemic Attack Patients

    EBioMedicine 14 131-138. .

    [doi:10.1016/j.ebiom.2016.11.010]

  • Vena, AB; Cambray, S; Molina-Seguin, J; Colàs-Campàs L; Sanahuja, J; Quilez, A; Gonzalez-Mingot, C; Gil-Villar, MP; Benabdelhak, I; Mauri-Capdevila, G; Purroy, F

    Clinical Evolution of Elderly Adults with Ischemic Stroke

    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY 64 2167-2170. .

    [doi:10.1111/jgs.14426]

  • Purroy F; Suárez-Luis I; Cambray S; Farré J; Benabdelhak I; Mauri-Capdevila G; Sanahuja J; Quílez A; Begué R; Gil MI; Molina-Seguin J; Torreguitart N

    The determination of copeptin levels helps management decisions among transient ischaemic attack patients

    ACTA NEUROLOGICA SCANDINAVICA 134 140-147. .

    [doi:10.1111/ane.12523]

  • Vilanova MB; Mauri-Capdevila G; Sanahuja J; Quilez A; Piñol-Ripoll G; Begué R; Gil MI; Codina-Barios MC; Benabdelhak I; Purroy F

    Prediction of myocardial infarction in patients with transient ischaemic attack

    ACTA NEUROLOGICA SCANDINAVICA 131 111-119. .

    [doi:10.1111/ane.12291]

  • Jové M; Mauri-Capdevila G; Suárez I; Cambray S; Sanahuja J; Quílez A; Farré J; Benabdelhak I; Pamplona R; Portero-Otín M; Purroy F

    Metabolomics predicts stroke recurrence after transient ischemic attack

    Neurology 84 36-45. .

    [doi:10.1212/WNL.0000000000001093]

  • Purroy F; Suárez-Luis I; Mauri-Capdevila G; Cambray S; Farré J; Sanahuja J; Piñol-Ripoll G; Quílez A; González-Mingot C; Begué R; Gil MI; Fernández E; Benabdelhak I

    N- terminal pro- brain natriuretic peptide level determined at different times identifies transient ischaemic attack patients with atrial fibrillation

    EUROPEAN JOURNAL OF NEUROLOGY 21 679-683. .

    [doi:10.1111/ene.12222]

  • Purroy, F; Jove, M; Mauri-Capdevila, G; Suarez, I; Cambray, S; Sanahuja, J; Benabdelhak, I; Farre, J; Portero-Otin, M

    METABOLOMICS PREDICTS STROKE RECURRENCE AFTER TRANSIENT ISCHEMIC ATTACK

    CEREBROVASCULAR DISEASES 37 159-160. .

  • Mauri-Capdevila, G; Jove, M; Suarez-Luis, I; Portero-Otin, M; Purroy, F

    Metabolomics in ischaemic stroke, new diagnostic and prognostic biomarkers

    REVISTA DE NEUROLOGIA 57 29-36. .

Projectes

  • Estudio multicéntrico de la aplicación del postcondicionamiento isquémico remoto en pacientes con ictus isquémico POST REMOTE
  • Determinación del tiempo de inicio del ictus isquémico y el tejido recuperable mediante la firma ómica: OMIC IS BRAIN
  • Percondicionamiento isquémico remoto en pacientes con ictus isquémico agudo en Catalunya (REMOTE-CAT) y modelo experimental de Per y Postcondicionamiento isquémico remotos